Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2005
06/15/2005EP1539793A2 Humanized anti-lymphotoyin beta receptor antibodies
06/15/2005EP1539786A2 Humanized renilla reniformis green fluorescent protein as a scaffold
06/15/2005EP1539785A2 Gene regulation in transgenic animals using a transposon-based vector
06/15/2005EP1539784A2 Chitinase encoding dna molecule from cotton expressed preferentially in fibers during secondary cell wall deposition and the corresponding promoter
06/15/2005EP1539689A2 Antisense modulation of endothelial lipase expression
06/15/2005EP1539282A2 Improved injection system
06/15/2005EP1539228A2 Novel composition and methods for the treatment of immune related diseases
06/15/2005EP1539199A2 Methods and compositions for in vivo clearance of pathogens
06/15/2005EP1539197A2 Treatment of tumor cells for use in immunotherapy of cancer
06/15/2005EP1538913A2 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
06/15/2005EP1538896A1 High yielding soybean plants with increased seed protein plus oil
06/15/2005EP1415158B1 Method for selecting antibody expressing cells
06/15/2005EP1309625B1 Therapeutic compounds for ovarian cancer
06/15/2005EP1257566A4 Method of treating disorders of the eye
06/15/2005EP1248836B1 Method for preparing vaccines by using hybrid cells
06/15/2005EP1212420B1 Conditional immortalisation of cells
06/15/2005EP1163340B1 Compositions and methods for the modification of gene expression
06/15/2005EP1106692B1 Rna virus vector having contact infiltration capability
06/15/2005EP1066050B1 Application of hsp70 proteins
06/15/2005EP1015035A4 Vaccination by topical application of genetic vectors
06/15/2005EP1007713B1 Dna expression in transfected cells and assays carried out in transfected cells
06/15/2005EP0996732B1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants
06/15/2005EP0973380B1 Model for chronic cerebral inflammation by intracerebral injection of polynucleotide
06/15/2005EP0955948B1 Induction of immunological tolerance
06/15/2005EP0946743B1 A method of enhancing the rate of transfection of cells
06/15/2005EP0914344B1 ASSAY AND REAGENTS FOR QUANTIFYING hBNP
06/15/2005EP0815213B1 An immortalized mammal hybridoma fusion partner
06/15/2005EP0663956B1 Dna sequences which lead to the formation of polyfructans (levans), plasmids containing these sequences as well as a process for preparing transgenic plants
06/15/2005CN1628249A Paramycobacterial diagnostics and vaccines
06/15/2005CN1628179A Gene and protein relating to hepatocellular carcinoma
06/15/2005CN1628174A Recombination systems and a method for removing nucleic acid sequences from the genome of eukaryotic organisms
06/15/2005CN1628169A Artificial human chromosome containing human antibody lambda light chain gene
06/15/2005CN1628167A Interleukin-2 gene transferred lymphokine activated killer cells
06/15/2005CN1628166A Method of culturing liver cells over long time
06/15/2005CN1628128A Mammal prolactin variants
06/15/2005CN1628126A Modified transferrin fusion proteins
06/15/2005CN1627074A Method for detecting specificities of activated lymphocyte
06/15/2005CN1626669A Preparation of full-length human antibody
06/15/2005CN1626663A Expression vector for siRNA of mammal cell
06/15/2005CN1626662A Genes for the synthesis of antipathogenic substances
06/15/2005CN1626661A Phytohemagglutinin and application
06/15/2005CN1626655A Synthetase-1b for human cholesterol ester and coded sequence
06/15/2005CN1626653A Neutral protease (NP) and product by using neutral protease for tissue dissociation as well as method for the production thereof
06/15/2005CN1626651A System for culturing human embryonic stem cell and culturing method
06/15/2005CN1626553A Monoclonal antibody for anti ligand of human apopain 2
06/15/2005CN1626552A Angiogenesis related molecules
06/15/2005CN1206358C DNA sequence of a gene of hydroxy-phenyl pyruvate dioxygenase and production of plants containing a gene of hydroxy-phenyl pyruvate dioxygenase and which are tolerant to certain herbicides
06/15/2005CN1206357C Nucleic acid molecules which code for enzyme with fructosyltransferase activity and use thereof
06/15/2005CN1206354C Plant gene promotor for quickly inducing defect stimulation and high efficienly expression
06/15/2005CN1206352C Usage of xylanase for prepn. of foods
06/15/2005CN1206346C Culture cell of Ficus pumilal & method for tissue culture of Ficus pumila L with the same cell
06/15/2005CN1206340C Culture medium using sericin as nitrogen source
06/15/2005CN1206241C Novel natural antibacterial peptide, its code sequence and application
06/15/2005CN1206237C Low allergenic proteinvariants
06/14/2005US6906237 Vivo assay for anti angiogenic compounds
06/14/2005US6906176 Polypeptide or use in the fibrinolysis, digestion and coagulation
06/14/2005US6906175 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor.
06/14/2005US6906174 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor
06/14/2005US6906173 Expression vector coding transport protein for use in the diagnosis and treatment of cell proliferative, nervous system, diabetic and vision defects
06/14/2005US6905877 Compositions and methods for altering amino acid content of proteins
06/14/2005US6905876 Methods and compositions for in vitro germination and propagation of polygonatum cirrhifolium royle
06/14/2005US6905875 Non-disruptive three-dimensional culture and harvest system for anchorage-dependent cells
06/14/2005US6905874 Contacting T-cells with a surface that has attached thereto one or more agents that ligate a cell surface moiety and applying a force that drives cell concentration and cell surface moiety ligation
06/14/2005US6905866 Sigma binding region of RNA polymerase and uses thereof
06/14/2005US6905856 Soluble GlcNAc phosphotransferase
06/14/2005US6905855 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
06/14/2005US6905847 Method of increasing product expression through solute stress
06/14/2005US6905846 Nucleic acids encoding factor X deletion mutants and analogues thereof
06/14/2005US6905845 Isolated nucleic acids; allergies sensitivity
06/14/2005US6905844 Human cervical cancer 2 protooncogene and protein encoded therein
06/14/2005US6905831 Real time measurement of cellular responses
06/14/2005US6905688 Comprises therapeutic fusion proteins for diagnosis and treatment of cancers, neovascularization and autoimmune diseases
06/14/2005US6905687 Fusion proteins; immunogens; solid phase synthesis; kits
06/14/2005US6905685 Antiproliferative agents; monoclonal antibodies; blocking immunology response; autoimmune disease, antidiabetic agents, antiarthritic agents, antitumor, anticancer agents
06/14/2005US6905683 Prevents side effects such as systemic activation of coagulation system, bleeding
06/14/2005US6905681 Methods for selectively stimulating proliferation of T cells
06/14/2005US6905680 Induction of lymphocytes; obtain cells, activate cells, incubate with activator, monitor lymphocyte proliferation
06/14/2005US6905678 Gene delivery vectors with cell type specificity for mesenchymal stem cells
06/14/2005US6905676 Cytokines; anttumor agents; viricides; bactericides; antiinflammatory agents
06/14/2005CA2308142C Anti-idiotype monoclonal antibodies, their use in active immunotherapy of malignant tumors and compositions containing them
06/14/2005CA2284100C New gene with upregulated expression in metastatic human tumor cells and a protein coded thereby, methods of production, and use thereof
06/14/2005CA2264585C Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions
06/14/2005CA2164088C Plasmids suitable for gene therapy
06/14/2005CA2106718C Methods for the production of hybrid seed
06/14/2005CA2100423C Parathyroid hormone analogs having parathyroid hormone-like activity
06/14/2005CA2072656C Transgenic plants having a modified carbohydrate content
06/10/2005CA2489266A1 Reagents for detecting efavirenz
06/09/2005WO2005052186A1 Means and methods for the determination of camp in vitro and in vivo
06/09/2005WO2005052178A1 A method of being biological transformed using resting cells in cloud point system
06/09/2005WO2005052172A1 Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (lcmv)
06/09/2005WO2005052170A2 Gene silencing by using micro-rna molecules
06/09/2005WO2005052142A1 Method of reducing embryonic stem cell differentiation
06/09/2005WO2005052141A1 Inhibition of stem cell differentiation, enhancement of proliferation and selective induction of apoptosis by wnt factors
06/09/2005WO2005052140A2 Multipotent postnatal stem cells from human periodontal ligament and uses thereof
06/09/2005WO2005052139A2 Method of inducing memory b cell development and terminal differentiation
06/09/2005WO2005052138A1 Cryopreservation of pluripotent stem cells
06/09/2005WO2005052137A1 Tangential flow filtration devices and methods for stem cell enrichment
06/09/2005WO2005052136A1 Process for recycling solid supports for cultivation of anchorage-dependent cells
06/09/2005WO2005051927A1 Method of culturing cd4-positive t cells via stimulation culture of hiv-1-infected pheripheral monocytes and hiv-1 growth inhibitor
06/09/2005WO2005051436A2 Method for tooth organ reconstruction
1 ... 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 ... 1827